DiaMedica Therapeutics  logo
DiaMedica Therapeutics DMAC
$ 4.07 1.24%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

DiaMedica Therapeutics EV/EBITDA Ratio 2011-2024 | DMAC

Annual EV/EBITDA Ratio DiaMedica Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.7 -10.2 -4.29 -2.31 -6.06 -4.55 -5.6 -0.574 -6.62 -6 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.574 -10.2 -4.89